...
首页> 外文期刊>Journal of diabetes and its complications >Differential alterations of spontaneous and stimulated 45Ca(2+) uptake by platelets from patients with type I and type II diabetes mellitus.
【24h】

Differential alterations of spontaneous and stimulated 45Ca(2+) uptake by platelets from patients with type I and type II diabetes mellitus.

机译:血小板来自I型和II型糖尿病患者的血小板血小板的差异改变。

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetes mellitus (DM) is associated with hyperaggregability of platelets. Although the mechanisms underlying this abnormality remain unknown, Ca(2+) imbalance has been implicated. Both activators (alpha-adrenoceptor agonists, collagen, and ADP) and inhibitors (beta-adrenoceptor agonists, iloprost and dibutyryl cAMP) of platelet function, respectively, elicit the uptake of [45Ca(2+)] in human platelets. It was determined that the [45Ca(2+)] uptake methods employed reflected signal transduction events at the plasma membrane rather than absolute changes of Ca(2+) fluxes or levels of cytosolic Ca(2+). In the present study, basal (unstimulated) [45Ca(2+)] uptake by platelets from both type I and type II diabetic patients was significantly enhanced when compared to age-matched controls. When basal values were subtracted from stimulated values, there were highly significant decreases in [45Ca(2+)] uptake in platelets from type I diabetic patients compared to controls when stimulated with adrenaline, isoprenaline, noradrenaline, collagen, A23187, or iloprost. In contrast, when basal values were subtracted from stimulated values there were significant increases in [45Ca(2+)] uptake by platelets from type II diabetic patients when stimulated with adrenaline, isoprenaline, noradrenaline, A23187, iloprost, and collagen. It is concluded that in type I and type II DM there are differential alterations in [45Ca(2+)] sequestration linked to inhibitors and stimulators of platelet activation. These data indicate that the hyperaggregability of platelets that is associated with both type I and type II DM may be due to an aetiology other than Ca(2+) mobilization linked to signal transduction.
机译:糖尿病(DM)与血小板的高硅合金有关。虽然这种异常的基础仍然未知,但是涉及CA(2+)不平衡。血小板函数的激活剂(α-肾上腺素依赖剂激动剂,胶原和ADP)和抑制剂(β-肾上腺素受体激动剂,ILOPROST和DIBUTYL CAMP)分别引发人血小板中[45CA(2+)]的吸收。确定[45CA(2+)]摄取方法采用血浆膜的反射信号转导事件,而不是Ca(2+)助熔剂或细胞溶胶Ca(2+)的绝对变化。在本研究中,与年龄匹配的对照相比,基础(非刺激)[45CA(2+)]通过血小板的血小板摄取和II型糖尿病患者的摄取显着提高。当从受刺激值中减去基底值时,与肾上腺素,异丙肾上腺素,去甲肾上腺素,胶原蛋白,A23187或ILOPROST刺激时,从I型糖尿病患者的血小板摄取的[45CA(2+)摄取是否有显着降低。相反,当从刺激的值中减去基底值时,在肾上腺素,异丙酚,去甲肾上腺素,A23187,Iloprost和胶原蛋白刺激时,通过II型糖尿病患者的血小板通过血小板通过血小板产生显着增加。结论是,在I型和II型DM中,[45CA(2+)]与血小板活化的抑制剂和刺激器连接的叠加中存在差异改变。这些数据表明,与I型和II型DM相关的血小板的高可gregabity可能是由于CA(2+)动员以外的疾病,与信号转导联系起来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号